業績
業績 - 2022年(Excel)業績 - 2021年(Excel)
英文（2016～2023年）
2023年
rognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study.
Shiba H, Kotani T, Nagai K, Hata K, Yamamoto W, Yoshikawa A, Wada Y, Hiramatsu Y, Makino H, Ueda Y, Onishi A, Murata K, Amuro H, Son Y, Hara R, Hirano T, Ebina K, Katayama M, Hashimoto M, Takeuchi T.
Int J Mol Sci. 2023 Apr 17;24(8):7399. doi: 10.3390/ijms24087399. PMID: 37108561 Free PMC article.
Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study.
Omura S, Kida T, Noma H, Sunaga A, Kusuoka H, Kadoya M, Nakagomi D, Abe Y, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Hirata S, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Yajima N, Kawaguchi T, Fukuda W, Kawahito Y.
Rheumatology 2023; kead138. doi.org/10.1093/rheumatology/kead138
The Impact of Early Optimization of Infliximab Blood Concentrations >1 µg/mL on Therapeutic Effectiveness in Rheumatoid Arthritis.
Nozaki Y, Kotani T, Takeuchi T, Hidaka T, Miyake H, Hatta K, Kurosawa Y, Sudo M, Ito S, Kinoshita K, Matsumura I.
Front Biosci (Landmark ed). 2023
Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study.
Omura S, Kida T, Noma H, Sunaga A, Kusuoka H, Kadoya M, Nakagomi D, Abe Y, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Hirata S, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Yajima N, Kawaguchi T, Fukuda W, Kawahito Y.
Rheumatology 2023; kead138. doi.org/10.1093/rheumatology/kead138
The Impact of Early Optimization of Infliximab Blood Concentrations >1 µg/mL on Therapeutic Effectiveness in Rheumatoid Arthritis.
Nozaki Y, Kotani T, Takeuchi T, Hidaka T, Miyake H, Hatta K, Kurosawa Y, Sudo M, Ito S, Kinoshita K, Matsumura I.
Front Biosci (Landmark ed). 2023
2022年
Association between serum biomarkers and peripheral neuropathy in microscopic polyangiitis.
Masuda Y, Matsuda S, Kotani T, Nishioka D, Ota S, Hosokawa T, Ishida S, Takeuchi T.
Int J Mol Sci 2022; 23:13374. doi:10.3390/ijms232113374.
Hypertrophic pachymeningitis in ANCA-associated vasculitis: A cross-sectional and multi- institutional study in Japan (J-CANVAS).
Shimojima Y, Kishida D, Ichikawa T, Kida T, Yajima N, Omura S, Nakagomi D, Abe Y, Kadoya M, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Hirata S, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Kawaguchi T, Kawahito Y, Sekijima Y.
Arthritis Res Ther. 2022; 24(1):204. doi: 10.1186/s13075-022-02898-4.
Examination of nailfold videocapillaroscopy findings in ANCA-associated vasculitis.
Matsuda S, Kotani T, Wakura R, Suzuka T, Kuwabara H, Kiboshi T, Wada Y, Shiba H, Hata K, Shoda T, Hirose Y, Takeuchi T.
Rheumatology (Oxford). 2022 Jul 11:keac402. doi: 10.1093/rheumatology/keac402.
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
Nakayama Y, Watanabe R, Murakami K, Murata K, Tanaka M, Ito H, Yamamoto W, Ebina K, Hata K, Hiramatsu Y, Katayama M, Son Y, Amuro H, Akashi K, Onishi A, Hara R, Yamamoto K, Ohmura K, Matsuda S, Morinobu A, Hashimoto M.
Rheumatol Int. 2022 Jul;42(7):1227-1234. doi: 10.1007/s00296-021-05086-w.
The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study.
Murata K, Uozumi R, Hashimoto M, Ebina K, Akashi K, Onishi A, Nagai K, Yoshikawa A, Katayama M, Son Y, Amuro H, Hara R, Yamamoto W, Watanabe R, Murakami K, Tanaka M, Ito H, Morinobu A, Matsuda S.
Mod Rheumatol. 2022 Jul 1;32(4):834-838. doi: 10.1093/mr/roab043.
Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
Ooe T, Matsuda S, Kotani T, Takeuchi T.
Rheumatology (Oxford). 2022 May 12:keac291. doi: 10.1093/rheumatology/keac291.
Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis.
Matsuda S, Kotani T, Takeuchi T.
Rheumatology (Oxford) 2022 Aug 30; 61(9):e282-e283. doi:10.1093/rheumatology/keac121.
Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report.
Matsuda S, Yamamoto M, Kotani T, Takeuchi T.
Rheumatol Adv Pract. 2022 Feb 10;6(1):rkac003. doi: 10.1093/rap/rkac003.
Examination of nailfold videocapillaroscopy findings in ANCA-associated vasculitis
Shogo Matsuda , Takuya Kotani , Reiko Wakura , Takayasu Suzuka , Hiroko Kuwabara , Takao Kiboshi , Yumiko Wada , Hideyuki Shiba , Kenichiro Hata , Takeshi Shoda , Yoshinobu Hirose , Tohru Takeuchi .
Rheumatology (Oxford). 2022 Jul 11;keac402.
Adipose-derived stem/stromal cells with heparin-enhanced anti-inflammatory and antifibrotic effects mitigate induced pulmonary fibrosis in mice
Takashi Saito , Takuya Kotani , Takayasu Suzuka , Shogo Matsuda , Tohru Takeuchi , Takako Sato .
Biochem Biophys Res Commun. 2022 Nov 12;629:135-141.
The addition of iguratimod can reduce methotrexate dose in rheumatoid arthritis with clinical remission
Ayaka Yoshikawa , Takuya Kotani , Shogo Matsuda , Kenichiro Hata , Yoko Matsumura , Tohru Takeuchi .
Mod Rheumatol. 2022 Jan 5;32(1):68-73.
Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort study
Hidehiko Makino 1, Takuya Kotani , Kenichiro Hata , Daisuke Nishioka , Wataru Yamamoto , Ayaka Yoshikawa , Yumiko Wada 1 Yuri Hiramatsu , Hideyuki Shiba , Koji Nagai , Masaki Katayama , Yonsu Son , Hideki Amuro , Akira Onishi , Kengo Akashi , Ryota Hara , Toru Hirano , Motomu Hashimoto , Tohru Takeuchi .
Mod Rheumatol. 2022 Sep 16;roac115.
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis
Takao Kiboshi , Takuya Kotani , Junichi Konma , Hidehiko Makino , Shogo Matsuda , Takayasu Suzuka , Yumiko Wada , Hideyuki Shiba , Kenichiro Hata , Takeshi Shoda , Tohru Takeuchi .
Mod Rheumatol. 2022 Feb 28;32(2):358-364.
Human MIKO-1, a Hybrid Protein That Regulates Macrophage Function, Suppresses Lung Fibrosis in a Mouse Model of Bleomycin-Induced Interstitial Lung Disease
Takuya Kotani , Masaki Ikemoto , Shogo Matsuda , Ryota Masutani , Tohru Takeuchi.
Int J Mol Sci. 2022 Aug 26;23(17):9669
Add-on Effectiveness of Methotrexate or Iguratimod in Patients with Rheumatoid Arthritis Exhibiting an Inadequate Response to Janus Kinase Inhibitors: The ANSWER Cohort Study
Kosuke Ebina , Toru Hirano , Yuichi Maeda , Yasutaka Okita , Yuki Etani , Makoto Hirao , Wataru Yamamoto , Motomu Hashimoto , Koichi Murata , Akira Onishi , Sadao Jinno , Ryota Hara , Yonsu Son , Hideki Amuro , Takuya Kotani , Hideyuki Shiba , Masaki Katayama , Keiichi Yamamoto , Atsushi Kumanogoh , Seiji Okada , Ken Nakata .
Mod Rheumatol. 2022 Aug 13;roac092.
Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
Takayasu Suzuka , Takuya Kotani , Takashi Saito , Shogo Matsuda , Takako Sato , Tohru Takeuchi .
Arthritis Res Ther. 2022 Oct 7;24(1):228.
Comment on: Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis.
Matsuda S, Kotani T, Takeuchi T.
Rheumatology (Oxford). 2022 Mar 8:keac121.
Comment on: Nailfold capillaries and myositis specific antibodies in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
Matsuda S, Kotani T, Takeuchi T.
Rheumatology (Oxford). 2022 May 5;61(5):e120-e121.
Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report.
Matsuda S, Yamamoto M, Kotani T, Takeuchi T.
Rheumatol Adv Pract. 2022 Feb 10;6(1):rkac003.
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
Ebina K, Hirano T, Maeda Y, Yamamoto W, Hashimoto M, Murata K, Onishi A, Jinno S, Hara R, Son Y, Amuro H, Takeuchi T, Yoshikawa A, Katayama M, Yamamoto K, Okita Y, Hirao M, Etani Y, Kumanogoh A, Okada S, Nakata K.
Sci Rep. 2022 Jan 7;12(1):134.
Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply.
Matsuda S, Yamamoto M, Kotani T, Takeuchi T.
Rheumatol Adv Pract. 2022 Apr 11;6(1):rkac025.
Association of M2 macrophages, Th2, and B cells with pathomechanism in microscopic polyangiitis complicated by interstitial lung disease.
Matsuda S, Kotani T, Kuwabara H, Suzuka T, Kiboshi T, Wada Y, Ishida T, Fujiki Y, Shiba H, Hata K, Shoda T, Hirose Y, Takeuchi T.
J Rheumatol. 2022 May 2:jrheum.220123
Low-Molecular-Weight Heparin Enhanced Therapeutic Effects of Human Adipose-Derived Stem Cell Administration in a Mouse Model of Lupus Nephritis.
Matsuda S, Kotani T, Saito T, Suzuka T, Mori T, Takeuchi T.
Front Immunol. 2022 Jan 13;12:792739.
Congenital cytomegalovirus infection after maternal primary infection in a patient with systemic lupus erythematosus: A case report and literature review.
Nakamura E, Isoda K, Kotani T, Hiramatsu Y, Wada Y, Fujiki Y, Fujita D, Takeuchi T.
Lupus. 2022 Feb;31(2):256-260.
Low pre-pregnant body mass index is a risk factor for the decrease of postpartum bone mineral density in systemic lupus erythematosus patients received glucocorticoid therapy.
Ishida T, Yuri H, Nakamura E, Isoda K, Wada Y, Kotani T, Takeuchi T.
Lupus. 2022 Apr 19:9612033221094710
2021年
Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy.
Tsukahara A, Hosokawa T, Nishioka D, Kotani T, Ishida S, Takeuchi T, Kimura F, Arawaka S.
Sci Rep. 2021 Nov 24;11(1):22827.
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis.
Kiboshi T, Kotani T, Konma J, Makino H, Matsuda S, Suzuka T, Wada Y, Shiba H, Hata K, Shoda T, Takeuchi T.
Mod Rheumatol. 2021 Aug 31:1-7.
Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study.
Jinno S, Onishi A, Dubreuil M, Hashimoto M, Yamamoto W, Murata K, Takeuchi T, Kotani T, Maeda Y, Ebina K, Son Y, Amuro H, Hara R, Katayama M, Saegusa J.
Arthritis Res Ther. 2021 Apr 15;23(1):116.
Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus.
Hiramatsu Y, Isoda K, Kotani T, Nakamura E, Wada Y, Fujiki Y, Makino S, Fujita D, Takeuchi T.
Arthritis Res Ther. 2021; 23(1): 140.
Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease.
Matsuda S, Kotani T, Suzuka T, Kiboshi T, Fukui K, Wakama M, Ishida T, Fujiki Y, Shiba H, Nagai K, Hata K, Shoda T, Ito Y, Makino S, Takeuchi T.
Sci Rep. 2021; 11(1): 1490.
CCL2 Produced by CD68+/CD163+ Macrophages as a Promising Clinical Biomarker of Microscopic Polyanigiitis-Interstitial Lung Disease.
Matsuda S, Kotani T, Kuwabara H, Suzuka T, Kiboshi T, Fukui K, Ishida T, Fujiki Y, Shiba H, Hata K, Shod T, Hirose Y, Takeuchi T.
Rheumatology (Oxford). 2021, inpress.
Effects of denosumab on rheumatic diseases and refractory glucocorticoid-induced osteoporosis: a prospective study.
Ishida T, Yoshida S, Fujiki Y, Hata K, Kotani T, Takeuchi T.
Arch Osteoporos. 2021; 16(1): 39.
The addition of iguratimod can reduce methotrexate dose in rheumatoid arthritis with clinical remission.
Yoshikawa A, Kotani T, Matsuda S, Hata K, Matsumura Y, Takeuchi T.
Mod Rheumatol. 2021, inpress.
Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis.
Nakamura E, Kotani T, Hiramatsu Y, Hata K, Yoshikawa A, Matsumura Y, Tokai N, Wada Y, Fujita D, Takeuchi T.
Mod Rheumatol. 2021 Jul;31(4):809-816.
2020年
Short- and Long-Term Prognosis of Polymyositis/Dermatomyositis with Acute/Subacute Interstitial Pneumonia: A Retrospective Study.
Hata K, Kotani T, Fujiki Y, Matsuda S, Suzuka T, Ishida T, Makino S, and Takeuchi T.
Bulletin of the Osaka Medical College. 2020; 66 (1,2) : 17–27.
Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice.
Saito T, Kotani T, Suzuki K.
Sci Rep. 2020; 10(1): 19019.
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study.
Ebina K, Hirano T, Maeda Y, Yamamoto W, Hashimoto M, Murata K, Takeuchi T, Nagai K, Son Y, Amuro H, Onishi A, Jinno S, Hara R, Katayama M, Yamamoto K, Kumanogoh A, Hirao M.
Clin Rheumatol. 2020; 39(9): 2563-2572.
Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study.
Jinno S, Onishi A, Dubreuil M, Akashi K, Hashimoto M, Yamamoto W, Murata K, Takeuchi T, Kotani T, Maeda Y, Ebina K, Son Y, Amuro H, Hara R, Katayama M, Saegusa J, Morinobu A.
Rheumatol Int. 2020; 40(12): 1987-1995.
Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study.
Ishida T, Kotani T, Serada S, Fujimoto M, Takeuchi T, Makino S, Naka T.
PLoS One. 2020 Jun 1;15(6):e0234090.
Comparison of Nailfold Videocapillaroscopy Findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in Patients with Dermatomyositis Complicated by Interstitial Lung Disease
Wakura R, Matsuda S, Kotani T, Shoda T, Takeuchi T.
Sci Rep. 2020; 10(1): 15692.
Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung disease.
Matsuda S, Kotani T, Ishida T, Fukui K, Fujiki Y, Suzuka T, Nagai K, Hata K, Shoda T, Isoda K, Ito Y, Makino S, Takeuchi T, Arawaka S.
Rheumatology (Oxford). 2020; 59 (2): 310-318
Drug Tolerability and Reasons for Discontinuation of Seven Biologics in Elderly Patients With Rheumatoid Arthritis -The ANSWER Cohort Study.
Kosuke Ebina, Motomu Hashimoto, Wataru Yamamoto, Toru Hirano, Ryota Hara, Masaki Katayama, Akira Onishi, Koji Nagai, Yonsu Son, Hideki Amuro, Keiichi Yamamoto, Yuichi Maeda, Koichi Murata, Sadao Jinno, Tohru Takeuchi, Makoto Hirao, Atsushi Kumanogoh, Hideki Yoshikawa.
PLoS One. 2019; 14 (5): e0216624.
Drug Tolerability and Reasons for Discontinuation of Seven Biologics in 4466 Treatment Courses of Rheumatoid Arthritis-The ANSWER Cohort Study.
Kosuke Ebina, Motomu Hashimoto, Wataru Yamamoto, Toru Hirano, Ryota Hara, Masaki Katayama, Akira Onishi, Koji Nagai, Yonsu Son, Hideki Amuro, Keiichi Yamamoto, Yuichi Maeda, Koichi Murata, Sadao Jinno, Tohru Takeuchi, Makoto Hirao, Atsushi Kumanogoh, Hideki Yoshikawa.
Arthritis Res Ther. 2019; 21 (1): 91.
The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy:
Murata K, Hashimoto M, Yamamoto W, Son Y, Amuro H, Nagai K, Takeuchi T, Katayama M, Maeda Y, Ebina K, Hara R, Jinno S, Onishi A, Murakami K, Tanaka M, Ito H, Mimori T, Matsuda S.
the ANSWER cohort study. Rheumatol Int. 2020; 40 (2): 217-225.
2019年
Efficacy and safety of oral high-trough level tacrolimus in acute/subacute interstitial pneumonia with dermatomyositis
Suzuka T, Kotani K, Takeuchi T, Fujiki Y, Hata K, Yoshida S, Shoda T, Makino S, Arawaka S.
Int J Rheum Dis. 2019 Feb;22(2):303-313.
Efficacy of abatacept tapering therapy for sustained remission in patients with rheumatoid arthritis: Prospective single-center study.
Yoshida S, Kotani T, Kimura Y, Matsumura Y, Yoshikawa A, Tokai N, Ozaki T, Nagai K, Takeuchi T, Makino S, Arawaka S.
Int J Rheum Dis. 2019 Jan;22(1):81-89
Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitis.
Tani H, Nagai K, Hosokawa T, Hata K, Kotani T, Ishida S, Takeuchi T, Arawaka S.
J Neurol. 2019 Jul;266(7):1708-1715.
Efficacy and safety of oral high-trough level tacrolimus in acute/subacute interstitial pneumonia with dermatomyositis.
Suzuka T, Kotani T, Takeuchi T, Fujiki Y, Hata K, Yoshida S, Shoda T, Makino S, Arawaka S.
Int J Rheum Dis. 2019 Feb;22(2):303-313.
Asymptomatic rheumatoid meningitis revealed by magnetic resonance imaging, followed by systemic rheumatic vasculitis: A case report and a review of the literature.
Matsuda S, Yoshida S, Takeuchi T, Fujiki Y, Yoshikawa A, Makino S.
Mod Rheumatol. 2019 Mar;29(2):370-376.
2018年
Changes in the blood level, efficacy, and safety of tacrolimus in pregnancy and the lactation period in patients with systemic lupus erythematosus
Hiramatsu Y, Yoshida S, Kotani T, Nakamura E, Kimura Y, Fujita D, Nagayasu Y, Shabana K, Makino S, Takeuchi T, Arawaka S.
LUPUS. 2018 in press.
Efficacy and safety of combination therapy with prednisolone and oral tacrolimus for progressive interstitial pneumonia with systemic sclerosis: A retrospective study.
Konma J, Kotani T, Shoda T, Suzuka T, Fujiki Y, Nagai K, Hata K, Yoshida S, Takeuchi T, Makino S, Arawaka S.
Mod Rheumatol. 2018 Nov;28(6):1009-1015.
Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.
Ishida T, Yoshida S, Kimura Y, Fujiki Y, Kotani T, Takeuchi T, Makino S, Arawaka S.
Lupus. 2018 Sep;27(10):1636-1643.
Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
Tokai N, Yoshida S, Kotani T, Yoshikawa A, Kimura Y, Fujiki Y, Matsumura Y, Takeuchi T, Makino S, Arawaka S.
PLoS One. 2018 Aug 23;13(8).
Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study.
Hashimoto M, Furu M, Yamamoto W, Fujimura T, Hara R, Katayama M, Ohnishi A, Akashi K, Yoshida S, Nagai K, Son Y, Amuro H, Hirano T, Ebina K, Uozumi R, Ito H, Tanaka M, Ohmura K, Fujii T, Mimori T.
Arthritis Res Ther. 2018 Aug 3;20(1):165.
Potential of Krebs von den Lungen-6 as a predictor of relapse in interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies-positive dermatomyositis.
Isoda K, Kotani T, Takeuchi T, Konma J, Ishida T, Hata K, Otani K, Fujiwara H, Shoda T, Makino S, Arawaka S.
Clin Respir J. 2018 Jul;12(7):2235-2241.
A case of scleritis associated rheumatoid arthritis accompanying an intraocular elevated lesion.
Kobayashi T, Takai N, Tada R, Shoda H, Kida T, Ikeda T, Ozaki T, Makino S.
BMC Ophthalmol. 2018 May 30;18(1):129.
Refractory chronic lupus peritonitis resolved by multitargeted therapy.
Matsuda S, Yoshida S, Nakamura E, Takeuchi T, Makino S.
Lupus. 2018 Apr;27(5):872-874.
Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature.
Matsuda S, Yoshida S, Fujiki Y, Satomi H, Takeuchi T, Hirose Y, Makino S, Arawaka S.
Rheumatol Int. 2018 Apr;38(4):689-696.
Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study.
Yoshikawa A, Yoshida S, Kimura Y, Tokai N, Fujiki Y, Kotani T, Matsumura Y, Takeuchi T, Makino S.
Mod Rheumatol. 2018 Mar;28(2):227-234.
Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
Ebina K, Hashimoto M, Yamamoto W, Ohnishi A, Kabata D, Hirano T, Hara R, Katayama M, Yoshida S, Nagai K, Son Y, Amuro H, Akashi K, Fujimura T, Hirao M, Yamamoto K, Shintani A, Kumanogoh A, Yoshikawa H.
PLoS One. 2018 Mar 15;13(3):e0194130.
Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients.
Fujiki Y, Kotani T, Isoda K, Ishida T, Shoda T, Yoshida S, Takeuchi T, Makino S.
Mod Rheumatol. 2018 Jan;28(1):133-140.
2017年
Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia.
Kotani T, Masutani R, Suzuka T, Oda K, Makino S, Ii M.
Sci Rep. 2017 Nov 6;7(1):14608.
Multimodality assessment of left ventricular dysfunction in Takayasu arteritis and familial hypercholesterolaemia.
Okada A, Takahama H, Ogura M, Morita Y, Konma J, Yoshida S, Makino S, Takashio S, Amaki M, Ohara T, Hasegawa T, Sugano Y, Kanzaki H, Harada-Shiba M, Ishibashi-Ueda H, Yasuda S, Hanafusa T, Anzai T.
ESC Heart Fail. 2017 Nov;4(4):655-659.
Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody.
Isoda K, Kotani T, Takeuchi T, Kiboshi T, Hata K, Ishida T, Otani K, Kamimori T, Fujiwara H, Shoda T, Makino S.
Rheumatol Int. 2017 Aug 37(8):1335-1340.
Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis.
Hisanaga J, Kotani T, Fujiki Y, Yoshida S, Takeuchi T, Makino S.
International Journal of Rheumatic Diseases. 2017 Dec;20(12):2182-2185.
Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study.
Oda K, Kotani T, Takeuchi T, Ishida T, Shoda T, Isoda K, Yoshida S, Nishimura Y, Makino S.
Sci Rep. 2017 May 9;7(1):1635.
Chylothorax in dermatomyositis complicated with interstitial pneumonia.
Isoda K, Kiboshi T, Shoda T.
Rheumatol Int. 2017 Apr 37(4):671-673
Gastrointestinal involvement at the onset of granulomatosis with polyangiitis: A case report.
Yoshikawa A, Yoshida S, Takeuchi T, Fujiki Y, Makino S, Hanafusa T.
Mod Rheumatol. 2017 Jan;27(1):162-164.
2016年
Asymptomatic rheumatoid meningitis revealed by magnetic resonance imaging, followed by systemic rheumatic vasculitis: A case report and a review of the literature.
Matsuda S, Yoshida S, Takeuchi T, Fujiki Y, Yoshikawa A, Makino S.
Mod Rheumatol. 2016 Sep 23:1-7.
Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?
Wakura D, Kotani T, Takeuchi T, Komori T, Yoshida S, Makino S, Hanafusa T.
PLoS One. 2016 Jul 6;11(7)
Initial limited three-level thin-section computed tomography scorings predict the prognosis of acute/subacute interstitial pneumonia in patients with dermatomyositis.
Kotani T, Takeuchi T, Yoshimatsu Y, Ishida T, Yamamoto N, Fujiki Y, Oda K, Isoda K, Hata K, Kamimori T, Fujiwara H, Makino S, Hanafusa T.
Mod Rheumatol. 2016 Sep;26(5):738-43.
和文（2015～2022年）
2022年
CD68+/CD163+マクロファージにより産生されるCCL2は間質性肺疾患合併顕微鏡的多発血管炎（MPA-ILD）の臨床バイオマーカーである．
松田翔悟、小谷卓矢、武内徹．
リウマチ科 科学評論社. 東京. 2022; 68(6)：704-711.
2021年
【呼吸器薬物療法-現場ではこう使いこなす】ステロイド薬, 免疫抑制薬.
小谷卓矢.
呼吸器ジャーナル. 2021; 69 (1): 132-141.
脳静脈血栓症を合併した劇症型抗リン脂質抗体症候群(CAPS)の1例.
田中 愛実, 三間 洋平, 安部 裕子, 礒田 健太郎, 井村 隼, 大原 真理子, 上田 直子, 池田 充, 庄田 武司, 森川 雅史, 大坪 亮
脳卒中. 2020; 42(5): 429-434.
2020年
CNSループスの現状と今後の展望
藤木陽平, 槇野茂樹．
リウマチ科 科学評論社. 東京. 2020; 63 (1): 146-152.
2019年
【妊娠と薬の使い方】膠原病と妊娠
槇野茂樹, 平松ゆり
日本医師会雑誌. 2019; 148 (2): 201-204.
【さまざまな状況下におけるRAマネジメント-対処法とその後のリウマチ治療】間質性肺炎
武内徹, 山川英晃.
リウマチ科 科学評論社. 東京. 2019; 62 (6): 503-508.
むかしの頭で診ていませんか？膠原病診療をスッキリまとめました リウマチ，アレルギーも載ってます！
膠原病の心・肺障害には何がある？
小谷卓矢
2019年10月発行
2018年
私の膠原病性間質性肺炎の診療
槇野茂樹
大阪医科大学雑誌 77(1-2):14-26, 2018
MMFは強皮症の肺病変に有効か？
槇野茂樹
リウマチ科 60(2):182-187, 2018
一般内科医が知っておくべき膠原病の知識 みつけ方・患者への対応
槇野茂樹
大阪府内科医会会誌 27(1):54-61, 2018
2017年
血漿交換療法を用いて治療した消化管穿孔合併の多発血管炎性肉下種症の一例(原著論文)
木坊子 貴生, 礒田 健太郎, 古川 皓一, 若原 智之, 大谷 賢一郎, 上田 佳世, 金万 淳一, 寺村 一裕, 植野 望, 藤原 寛, 庄田 武司
日本臨床免疫学会会誌 40(5):382-386, 2017
リウマチ診療における非結核性抗酸菌症のマネージメント(解説)
槇野茂樹
臨床リウマチ 29(4):292-299, 2017
多発性筋炎・皮膚筋炎の最新情報 Amyopathic dermatomyositis(解説/特集)
小谷卓也
炎症と免疫 25 (6): 504-512, 2017.
Granulomatosis with Polyangiitis Complicated with Gastrointestinal Perforation: A Case Report and Review of Literature.
Kiboshi T, Isoda K, Furukawa K, Wakahara T, Otani K, Ueda K, Konma J, Teramura K, Ueda N, Fujiwara H, Shoda T.
日本臨床免疫学会会誌. 2017;40(5):382-386
歯周病とRA発症リスク(解説/特集)
木村 侑子, 吉田 周造, 槇野 茂樹
Keynote R・A 5(2):65-68, 2017
2016年
RAの寛解と歯周病菌との関連(解説)
武内 徹, 吉田 周造, 木村 侑子
リウマチ科 56(4):410-416, 2016
大阪医科大学附属病院での生物学的製剤導入患者に対するリウマチ教室と個別リハビリテーションの取り組み(解説)
田村 裕子, 長尾 佳奈, 樋下 哲也, 吉川 紋佳, 橋口 宮子, 岩井 有香, 伊藤 大介, 小田 裕治, 大西 泰子, 遠近 太郎, 清水 和俊, 岩吹 綾子, 山本 了平, 大野 博司, 仲野 春樹, 土井 あかね, 吉田 周造, 武内 徹, 槙野 茂樹, 佐浦 隆一
日本RAのリハビリ研究会誌 30(1):41-46, 2016
膠原病性間質性肺炎の臨床 実態の解明とその治療・管理(解説)
槇野 茂樹
大阪医科大学雑誌 75(1-2):16-23, 2016
関節リウマチの発症や治療に環境要因がどうかかわるか(解説/特集)
木村 侑子, 吉田 周造, 槇野 茂樹
Medical Practice 33(10):1537-1541, 2016
眼窩脂肪容積の増大と続発緑内障をきたした再発性多発性軟骨炎の1例
石崎 典彦, 小嶌 祥太, 高井 七重, 勝村 ちひろ, 小林 崇俊, 植木 麻理, 杉山 哲也, 菅澤 淳, 池田 恒彦, 萩森 伸一, 槇野 茂樹
あたらしい眼科 33(7):1066-1069, 2016
細菌性肺炎の対策と予防(解説/特集)
庄田 武司, 槇野 茂樹
リウマチ科 56(1):38-44, 2016
多発血管炎性肉芽腫症(GPA)の診断と治療(解説)
庄田 武司, 槇野 茂樹
呼吸器内科 29(4):336-343, 2016
関節リウマチに伴う間質性肺炎・気道病変(解説/特集)
槇野 茂樹
リウマチ科 55(4):364-369, 2016
ベーチェット病の口腔粘膜病変（特集/解説）
山本祐三, 庄田武司, 黒川晃夫
JOHNS 32(11):1605-1611,2016
2015年
プロテオミクス解析と自己免疫疾患への応用(解説)
武内 徹
細胞 47(12):612-614, 2015
プロテオミクス解析と自己免疫疾患への応用(解説)
武内 徹
BIO Clinica 30(11):1102-1105, 2015
医薬品・薬物などによるミオパチー 好酸球増加筋痛症候群・毒性オイル症候群(解説/特集)
武内 徹
日本臨床 別冊骨格筋症候群(下) 324-327, 2015
間質性肺炎合併時の治療選択(解説/特集)
庄田 武司, 槇野 茂樹
リウマチ科 54(5):508-513, 2015
自己免疫性胸膜炎
小谷卓矢, 槇野茂樹
別冊日本臨床 新領域別症候群シリーズ. 34:401-405, 2015
全身性エリテマトーデス(SLE)
庄田 武司, 槇野 茂樹
呼吸器内科 27(4):1884-2887, 2015
生物学的製剤と呼吸器感染症対策(解説)
武内 徹, 槇野 茂樹
呼吸器内科 28(5):390-395, 2015
MTXと肺病変に関するメタ解析(解説)
吉田 周造, 槇野 茂樹
リウマチ科 53(2):182-186, 2015
著書
周術期におけるリウマチ性疾患治療薬の使い方．
武内徹.
脊椎脊髄ジャーナル 三和書店. 東京. 2022; 35(12):877-882.
Ⅰ治療学.
武内徹.
内科学(第十二版).朝倉書店.2022年3月：pp.I222-I226.
第8章免疫学．
武内徹.
NiCE微生物学・感染症学.南江堂.2020年11月：pp.146-165.
看護学テキストNICE微生物学・感染症学「第8章 免疫学」.
武内徹.
南江堂. 東京. 2021; pp.146-164.
医師ともっと話せるための基本的臨床医学知識
大八木 秀和，尾﨑 拓郎（一部共同執筆）
2017年4月27日発行
科学研究費助成事業
全身性強皮症に対する新規生物製剤hMIKO-1の有効性検証とその機序の解明
基盤（C) 小谷 卓矢
2023-04-01―2025-03-31
間質性肺炎合併関節リウマチに対するJAK阻害剤の安全性・有効性についての検討
若手（B) 吉川 紋佳
2023-04-01―2025-03-31
全身性強皮症に対する新規生物製剤hMIKO-1の有効性検証とその機序の解明
基盤（C） 小谷卓矢
2023-04-01 ―2 025-03-31
間質性肺炎合併関節リウマチに対するJAK阻害剤の安全性・有効性についての検討
若手（B） 吉川紋佳
2023-04-01 ― 2025-03-31
新規動物モデルを用いた、炎症による動脈硬化進展の病態解明、新規治療法の検索
若手研究 鈴鹿隆保
2021-04-01 – 2023-03-31
間質性肺炎に対する新規マクロファージ抑制タンパク質の抗炎症・線維化作用の検討
基盤研究C 武内徹
2021-04-01 – 2023-03-31
動脈硬化合併関節炎モデルマウスにおける新規機能性タンパク質の有効性の検討
若手研究 木坊子貴夫
2020-04-01 – 2022-03-31
膠原病合併間質性肺炎におけるS100タンパク質の臨床的意義の検討
若手研究 平松ゆり
2020-04-01 – 2022-03-31
脂肪組織由来幹細胞とスタチン製剤を用いた間質性肺炎マウスに対する治療効果の検討
小谷卓矢（代表者）
基盤研究C．2018年度～2020年度
皮膚筋炎合併間質性肺炎の病態形成機序の解明と疾患制御に向けたバイオマーカーの探索
槇野茂樹（代表者）
基盤研究C．2016年度～2018年度
関節リウマチによる動脈硬化病変の形成促進メカニズムの解明と危険因子の網羅的解析
武内徹（代表者）
基盤研究C．2016年度～2018年度
脂肪組織由来幹細胞を用いた間質性肺炎に対する新規治療法のモデルマウスにおける研究
小谷卓矢（代表者）
平成28年度科学研究費助成事業．若手研究B．2016年度～2017年度
脂肪組織由来幹細胞とスタチン製剤を用いた強皮症モデルマウスに対する治療効果の検討
永井孝治（代表者）
平成29年度科学研究費助成事業．若手研究B．2017年度～2018年度
脂肪組織由来幹細胞を用いた強皮症に対する新規治療法のモデルマウスにおける研究
和田裕美子（代表者）
平成29年度科学研究費助成事業．若手研究B．2017年度～2018年度
その他共同研究 研究助成
蛍光イメージングによるリウマチ性疾患の早期診断の協働の可能性検討
小谷 卓矢
大阪医科薬科大学 民間機関等共同研究（島津製作所） 2022年～
CD68+/CD163+マクロファージのmiRNA，mRNAの網羅的解析を用いた間質性肺炎合併顕微鏡的多発血管炎の新規バイオマーカーの探索
松田 翔悟
公益財団法人難病医学研究財団令和4年度医学研究奨励助成金 2022年～2024年